2026. Efficacy and Safety of Abrocitinib Versus Dupilumab in Patients Who Self-Identified as Having Skin of Color: A Post Hoc Analysis of JADE COMPARE. SKIN The Journal of Cutaneous Medicine. 10, 2 (Mar. 2026), s733. DOI:https://doi.org/10.25251/8r6ert44.